Moderna Therapeutics, University of Massachusetts Medical School
Melissa Moore received her PhD in biological chemistry from the Massachusetts Institute of Technology. She became interested in understanding RNA splicing during a post-doc with Phillip Sharp, also at MIT. Since then, Moore has spent much of her career working on the spliceosome and other mysteries of RNA processing. Moore was a Howard Hughes Medical Institute Investigator from 1997-2016. She is now Chief Scientific Officer at Moderna Therapeutics in Cambridge, MA, and is a part-time faculty member at the University of Massachusetts Medical School.
Melissa Moore talks about RNA processing to remove non-coding sequences, alternative splicing to produce more than one protein from a single gene, and the spliceosome. (Talk recorded in July 2011)